Literature DB >> 18722030

Serum osteoprotegerin is associated with carotid intima media thickness in women with previous gestational diabetes.

Baris Akinci1, Tevfik Demir, Aygul Celtik, Mustafa Baris, Serkan Yener, Mehmet Ali Ozcan, Faize Yuksel, Mustafa Secil, Sena Yesil.   

Abstract

Circulating levels of osteoprotegerin (OPG) have been shown to be increased in patients with cardiovascular disorders and diabetes. The aim of this study was to determine serum OPG levels in women with previous gestational diabetes (GDM), and to investigate the relationship between OPG and carotid intima media thickness (IMT) and circulating cardiovascular risk factors. Serum OPG was measured in 46 women with previous GDM and 30 age-matched healthy controls. Carotid IMT was evaluated. Serum lipid, insulin and hsCRP levels, plasma fibrinogen, vWF and PAI-1 levels were measured. Serum OPG levels tended to be increased in women with previous GDM (p=0.058). Carotid IMT was increased in the study group. Women with previous GDM had elevated levels of hsCRP and PAI-1. OPG levels were positively correlated with age, fasting and post-load glucose levels, hsCRP, and carotid IMT. Multiple regression analysis showed that serum OPG was a statistically significant predictor for elevated carotid IMT. Our results revealed that OPG levels tended to be elevated in women with previous GDM. Significant association of OPG with carotid IMT suggested that OPG might play a role in the pathogenesis of endothelial dysfunction in women with previous GDM.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18722030     DOI: 10.1016/j.diabres.2008.07.014

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  16 in total

1.  Noninvasive assessment of subclinical atherosclerosis in normotensive gravidae with gestational diabetes.

Authors:  A E Atay; H Simsek; B Demir; M N Sakar; M Kaya; S Pasa; S Demir; D Sit
Journal:  Herz       Date:  2013-07-18       Impact factor: 1.443

2.  The association of insulin resistance with serum osteoprotegerin in obese adolescents.

Authors:  Joanna Suliburska; Pawel Bogdanski; Ewa Gajewska; Grazyna Kalmus; Magdalena Sobieska; Wlodzimierz Samborski
Journal:  J Physiol Biochem       Date:  2013-05-22       Impact factor: 4.158

3.  Correlation of plasma osteoprotegerin (OPG) and receptor activator of the nuclear factor κB ligand (RANKL) levels with clinical risk factors in patients with advanced carotid atherosclerosis.

Authors:  Constantinos Giaginis; Aikaterini Papadopouli; Athina Zira; Athanasios Katsargyris; Christos Klonaris; Stamatios Theocharis
Journal:  Med Sci Monit       Date:  2012-10

4.  Previous gestational diabetes mellitus and markers of cardiovascular risk.

Authors:  Nikolaos Vrachnis; Areti Augoulea; Zoe Iliodromiti; Irene Lambrinoudaki; Stavros Sifakis; George Creatsas
Journal:  Int J Endocrinol       Date:  2012-03-18       Impact factor: 3.257

5.  Role of adipokines and other inflammatory mediators in gestational diabetes mellitus and previous gestational diabetes mellitus.

Authors:  Nikolaos Vrachnis; Panagiotis Belitsos; Stavros Sifakis; Konstantinos Dafopoulos; Charalambos Siristatidis; Kalliopi I Pappa; Zoe Iliodromiti
Journal:  Int J Endocrinol       Date:  2012-04-09       Impact factor: 3.257

Review 6.  Osteoprotegerin in Cardiometabolic Disorders.

Authors:  C Pérez de Ciriza; A Lawrie; N Varo
Journal:  Int J Endocrinol       Date:  2015-05-11       Impact factor: 3.257

Review 7.  Association of gestational diabetes mellitus (GDM) with subclinical atherosclerosis: a systemic review and meta-analysis.

Authors:  Jing-Wei Li; Si-Yi He; Peng Liu; Lin Luo; Liang Zhao; Ying-Bin Xiao
Journal:  BMC Cardiovasc Disord       Date:  2014-09-29       Impact factor: 2.298

8.  Increased carotid artery intima-media thickness in pregnant women with gestational diabetes mellitus.

Authors:  Gholamreza Yousefzadeh; Hashem Hojat; Ahmad Enhesari; Mostafa Shokoohi; Nahid Eftekhari; Mehrdad Sheikhvatan
Journal:  J Tehran Heart Cent       Date:  2012-11-30

9.  Associations of fetuin-A and osteoprotegerin with arterial stiffness and early atherosclerosis in chronic hemodialysis patients.

Authors:  Panagiotis Pateinakis; Aikaterini Papagianni; Stella Douma; Georgios Efstratiadis; Dimitrios Memmos
Journal:  BMC Nephrol       Date:  2013-06-12       Impact factor: 2.388

10.  Osteoprotegerin, Soluble Receptor Activator of Nuclear Factor- κ B Ligand, and Subclinical Atherosclerosis in Children and Adolescents with Type 1 Diabetes Mellitus.

Authors:  Irene Lambrinoudaki; Emmanouil Tsouvalas; Marina Vakaki; George Kaparos; Kimon Stamatelopoulos; Areti Augoulea; Paraskevi Pliatsika; Andreas Alexandrou; Maria Creatsa; Kyriaki Karavanaki
Journal:  Int J Endocrinol       Date:  2013-10-30       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.